Metastatic/Recurrent Breast Cancer
1 clinical trials · Condition
◉ Watch Metastatic/Recurrent Breast Cancer
| Record | Firm | Date |
|---|---|---|
| Pharmacokinetic Study of Tesmilifene (YMB1002) Plus Epirubicin and Cyclophosphamide in Metastatic Breast Cancer (NCT00364754) | YM BioSciences | 2004-05-01 |
Track Metastatic/Recurrent Breast Cancer automatically
Every clearance here is in the API, with alerts when new ones post.